CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 12,500 shares (grant or award)
- 4 Grant or award Director acquired 523 shares (grant or award)
- 4 Grant or award Director acquired 333 shares (grant or award)
- 4 Grant or award Director acquired 1,866 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief R&D Officer gave up 7,525 shares (to pay taxes)
- 4 Grant or award Director acquired 653 shares (grant or award)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,461 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 6,096 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,461 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,461 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 14,010 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 8,251 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 27,525 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 8,613 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,890 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 7,150 shares (to pay taxes)
- 4 Planned sale Director sold 7,000 shares at $7.54 ($52,780)
- 4 Grant or award Director acquired 750 shares (grant or award)
Page 4 of 49 · 965 filings